-transparent.png){kind=logo}
Fibrinolytic responses to infusion of 1-desamino-8-D-arginine-vasopressin (DDAVP) were assessed in 6 males with congenital nephrogenic diabetes insipidus (NDI), 6 carriers of the NDI gene and 6 normal control subjects. Tissue-type plasminogen activator (t-PA) activity and antigen increased significantly in normal subjects, while plasminogen activator inhibitor (PAI) activity decreased. None of these changes were observed in patients with NDI. In 2 female carriers, normal fibrinolytic responses were seen, while in the other carriers responses were delayed. These findings are consistent with the concept of a general V2-receptor defect in congenital NDI. DDAVP tests are of limited use in NDI carrier detection.
N Knoers, and
E J Brommer, and
H Willems, and
B A van Oost, and
L A Monnens
August 1993,
The Netherlands journal of medicine,
N Knoers, and
E J Brommer, and
H Willems, and
B A van Oost, and
L A Monnens
April 1988,
The New England journal of medicine,
N Knoers, and
E J Brommer, and
H Willems, and
B A van Oost, and
L A Monnens
January 1996,
Nephron,
N Knoers, and
E J Brommer, and
H Willems, and
B A van Oost, and
L A Monnens
February 1978,
Annals of internal medicine,
N Knoers, and
E J Brommer, and
H Willems, and
B A van Oost, and
L A Monnens
October 1998,
Endocrine journal,
N Knoers, and
E J Brommer, and
H Willems, and
B A van Oost, and
L A Monnens
September 1978,
Clinical endocrinology,
N Knoers, and
E J Brommer, and
H Willems, and
B A van Oost, and
L A Monnens
June 1988,
Boletin medico del Hospital Infantil de Mexico,
N Knoers, and
E J Brommer, and
H Willems, and
B A van Oost, and
L A Monnens
November 1974,
Deutsche medizinische Wochenschrift (1946),
N Knoers, and
E J Brommer, and
H Willems, and
B A van Oost, and
L A Monnens
July 1973,
Casopis lekaru ceskych,
N Knoers, and
E J Brommer, and
H Willems, and
B A van Oost, and
L A Monnens
December 1977,
Archives francaises de pediatrie,
